Michael Boehnke, PhD
Richard G. Cornell Distinguished University Professor of Biostatistics
Director, Center for Statistical Genetics
Director, Genome Science Training Program
Statistical design and analysis of human gene mapping studies of common multifactorial diseases. Genome-wide association and sequencing studies. Application to type 2 diabetes and related traits, and bipolar disorder.
CSO Neurodegenerative Diseases DHT at Eli Lilly and Company
Neurobiology, Neurodegeneration, Neuropharmacology, Neurodegenerative Diseases, Molecular Neuroscience, Brain Diseases, Neurological Diseases, Molecular Neurobiology, Neurological Disorders, Tau Proteins, Neuropathology, Tauopathies, Neurogenetics, Prion Diseases, TDP-43 Proteinopathies.
Bradley T. Hyman, MD, PhD
John B. Penney Professor of Neurology, Harvard Medical School
Alzheimer's Unit Director, MassGeneral Institute for Neurodegenerative Disease
Director, Massachusetts Alzheimer's Disease Research Center
Understanding the neuropathophysiologies and the genetic factors that underlie dementia (e.g., Alzheimer's disease, Lewy body dementia).
William Mobley, MD, PhD
Department Chair of the Department of Neurosciences at UCSD
Distinguished Professor, Neuro- & Behavioral Science
Neurobiology of neurotrophic factor actions and signaling and on the hypothesis that dysfunction of such signaling mechanisms contributes to neuronal dysfunction in developmental and age-related disorders of the nervous system.
Stephen S. Rich, PhD
Professor, Public Health Sciences
Director, Center for Public Health Genomics
Genetic basis of common human disease, including type 1 diabetes, diabetic complications, ischemic stroke, atherosclerosis; molecular methodology employed range from SNP genotyping to targeted sequencing to exome sequencing and, eventually, whole genome sequencing.